» Articles » PMID: 31488048

Using Parallelized Incremental Meta-docking Can Solve the Conformational Sampling Issue when Docking Large Ligands to Proteins

Overview
Publisher Biomed Central
Specialty Cell Biology
Date 2019 Sep 7
PMID 31488048
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Docking large ligands, and especially peptides, to protein receptors is still considered a challenge in computational structural biology. Besides the issue of accurately scoring the binding modes of a protein-ligand complex produced by a molecular docking tool, the conformational sampling of a large ligand is also often considered a challenge because of its underlying combinatorial complexity. In this study, we evaluate the impact of using parallelized and incremental paradigms on the accuracy and performance of conformational sampling when docking large ligands. We use five datasets of protein-ligand complexes involving ligands that could not be accurately docked by classical protein-ligand docking tools in previous similar studies.

Results: Our computational evaluation shows that simply increasing the amount of conformational sampling performed by a protein-ligand docking tool, such as Vina, by running it for longer is rarely beneficial. Instead, it is more efficient and advantageous to run several short instances of this docking tool in parallel and group their results together, in a straightforward parallelized docking protocol. Even greater accuracy and efficiency are achieved by our parallelized incremental meta-docking tool, DINC, showing the additional benefits of its incremental paradigm. Using DINC, we could accurately reproduce the vast majority of the protein-ligand complexes we considered.

Conclusions: Our study suggests that, even when trying to dock large ligands to proteins, the conformational sampling of the ligand should no longer be considered an issue, as simple docking protocols using existing tools can solve it. Therefore, scoring should currently be regarded as the biggest unmet challenge in molecular docking.

Citing Articles

Hydroxycinnamoyl-coenzyme A: tetrahydroxyhexanedioate hydroxycinnamoyl transferase (HHHT) from L.: phylogeny, expression pattern, kinetic parameters, and active site analysis.

Fanelli A, Stonoha-Arther C, Sullivan M PeerJ. 2025; 13:e19037.

PMID: 39989742 PMC: 11847488. DOI: 10.7717/peerj.19037.


Insights into structural vaccinology harnessed for universal coronavirus vaccine development.

Lim C, Leow C, Lim H, Kok B, Chuah C, Oliveira J Clin Exp Vaccine Res. 2024; 13(3):202-217.

PMID: 39144127 PMC: 11319108. DOI: 10.7774/cevr.2024.13.3.202.


Novel peptide inhibitor of human tumor necrosis factor-α has antiarthritic activity.

Sahu D, Gupta C, Yennamalli R, Sharma S, Roy S, Hasan S Sci Rep. 2024; 14(1):12935.

PMID: 38839973 PMC: 11153517. DOI: 10.1038/s41598-024-63790-6.


Unleashing Nature's potential: a computational approach to discovering novel VEGFR-2 inhibitors from African natural compound using virtual screening, ADMET analysis, molecular dynamics, and MMPBSA calculations.

Baammi S, El Allali A, Daoud R Front Mol Biosci. 2023; 10:1227643.

PMID: 37800126 PMC: 10548200. DOI: 10.3389/fmolb.2023.1227643.


A New Tool to Study the Binding Behavior of Intrinsically Disordered Proteins.

Upadhyay A, Ekenna C Int J Mol Sci. 2023; 24(14).

PMID: 37511544 PMC: 10380747. DOI: 10.3390/ijms241411785.


References
1.
McCarthy M, Pagba C, Prakash P, Naji A, van der Hoeven D, Liang H . Discovery of High-Affinity Noncovalent Allosteric KRAS Inhibitors That Disrupt Effector Binding. ACS Omega. 2019; 4(2):2921-2930. PMC: 6396121. DOI: 10.1021/acsomega.8b03308. View

2.
Muhammed M, Aki-Yalcin E . Homology modeling in drug discovery: Overview, current applications, and future perspectives. Chem Biol Drug Des. 2018; 93(1):12-20. DOI: 10.1111/cbdd.13388. View

3.
Dhanik A, McMurray J, Kavraki L . Binding modes of peptidomimetics designed to inhibit STAT3. PLoS One. 2012; 7(12):e51603. PMC: 3520966. DOI: 10.1371/journal.pone.0051603. View

4.
Rentzsch R, Renard B . Docking small peptides remains a great challenge: an assessment using AutoDock Vina. Brief Bioinform. 2015; 16(6):1045-56. DOI: 10.1093/bib/bbv008. View

5.
Yang Z, Nie Y, Yang G, Zu Y, Fu Y, Zhou L . Synergistic effects in the designs of neuraminidase ligands: analysis from docking and molecular dynamics studies. J Theor Biol. 2010; 267(3):363-74. DOI: 10.1016/j.jtbi.2010.08.029. View